158 related articles for article (PubMed ID: 31250117)
1. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass.
Eriksson O
Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117
[TBL] [Abstract][Full Text] [Related]
2. The development of a GPR44 targeting radioligand [
Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O
EJNMMI Res; 2018 Dec; 8(1):113. PubMed ID: 30588560
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Visualization of β-Cells by Targeting of GPR44.
Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of GPR44 by Antagonist [
Cheung P; Zhang B; Puuvuori E; Estrada S; Amin MA; Ye S; Korsgren O; Odell LR; Eriksson J; Eriksson O
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33923731
[TBL] [Abstract][Full Text] [Related]
5. Ramatroban-Based Analogues Containing Fluorine Group as Potential
Huang LA; Huang KX; Tu J; Kandeel F; Li J
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
[TBL] [Abstract][Full Text] [Related]
6. GPR44 is a pancreatic protein restricted to the human beta cell.
Hellström-Lindahl E; Danielsson A; Ponten F; Czernichow P; Korsgren O; Johansson L; Eriksson O
Acta Diabetol; 2016 Jun; 53(3):413-21. PubMed ID: 26467464
[TBL] [Abstract][Full Text] [Related]
7. [
Cheung P; Amin MA; Zhang B; Lechi F; Korsgren O; Eriksson J; Odell LR; Eriksson O
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839820
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preclinical evaluation of the CRTH2 antagonist [
Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
Murakami T; Fujimoto H; Inagaki N
Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
[TBL] [Abstract][Full Text] [Related]
10. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
[TBL] [Abstract][Full Text] [Related]
11. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass.
Cline GW; Zhao X; Jakowski AB; Soeller WC; Treadway JL
Biochem Biophys Res Commun; 2011 Sep; 412(3):413-8. PubMed ID: 21820405
[TBL] [Abstract][Full Text] [Related]
12. Species differences in pancreatic binding of DO3A-VS-Cys
Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
[TBL] [Abstract][Full Text] [Related]
13. B-Glycine as a marker for β cell imaging and β cell mass evaluation.
Han Y; Liu H; Li Y; Liu Z
Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38632133
[TBL] [Abstract][Full Text] [Related]
14. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
[TBL] [Abstract][Full Text] [Related]
15. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas.
Di Gialleonardo V; Signore A; Scheerstra EA; Visser AK; van Waarde A; Dierckx RA; de Vries EF
J Nucl Med; 2012 Nov; 53(11):1755-63. PubMed ID: 23000748
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
[TBL] [Abstract][Full Text] [Related]
19. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
20. Visualizing pancreatic beta-cell mass with [11C]DTBZ.
Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE
Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
